CompoAtlas

NOCO +

NOCO +, licence 80148179: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
NOCO (Mapple leaf)
Licence holder
E. Excel LLC
NPN or DIN-HM
80148179
Status
Active licence
Licence date
30 March 2026
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Chrysanthemum x morifolium

Source : Chrysanthemum x morifolium - Flower

Extract : Matériel brut frais

Extraction ratio : 1:1

Dry plant equivalent : 21.4 mg

21.4 mgNot calculated
Ziziphus jujuba

Source : Ziziphus jujuba - Fruit

85.7 mgNot calculated
Panax ginseng

Source : Panax ginseng - racine

Extract : Matériel brut sec

Extraction ratio : 1:1

Dry plant equivalent : 85.7 mg

85.7 mgNot calculated
Glycyrrhiza glabra

Source : Glycyrrhiza glabra - racine

85.7 mgNot calculated
Ganoderma lucidum85.7 mgNot calculated
Mentha x piperita

Source : Mentha X piperita - feuille

64.3 mgNot calculated

Non-medicinal ingredients

Cellulose, Hydroxypropyl méthylcellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18.0 Année(s)7.0 Capsule1.0 Time Unit TBA

Uses authorised in Canada

Text supplied in English because no French text is available.

Combination of Traditional Chinese Medicine Ingredients. Panax ginseng is used in Traditional Chinese Medicine TCM to reinforce qi, benefit the spleen and lung, relieve symptoms of thirst due to impairment of body fluids and internal heat. Glycyrrhiza glabra is traditionally used in Herbal Medicine as an expectorant to help relieve (mucous buildup (catarrhs) and) cough associated with upper respiratory tract infections/cold. Reishi is used in Herbal medicine as a source of antioxidant and of fungal polysaccharides with immunomodulating properties. Panax ginseng is used in Herbal Medicine as an adaptogen to help increase energy and resistance to stress (e.g. in case of mental and physical fatigue related to stress).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80148179

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line